This page shows you your search results in order of relevance. This is page number 16.
Order by Relevance | Date
Total 817380 results found since Jan 2013.
Data for Merck ' s Investigational Once-Daily Formulation of ISENTRESS ® (raltegravir) Show That at Week 48, a Regimen Containing the Once-Daily Dosing Formulation...
Dateline City:
KENILWORTH, N.J. Resulted in Non-Inferior Efficacy and Safety to a Regimen Containing the Approved Twice-Daily Formulation EMA Accepts File Application, Plans Underway to Submit for Licensure to FDA This Year KENILWORTH, N.J.--( BUSINESS WIRE )--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
today announced efficacy and safety data in previously untreated adults
with HIV-1 infection for the company ’s investigational once-daily
formulation of ISENTRESS ® (raltegravir), known as raltegravir
600 mg (to be given as 2 x 600 mg), from the on...
Source: Merck.com - Research and Development News - July 22, 2016 Category: Pharmaceuticals Tags: Research and Development News Corporate News Latest News #Merck #MRK $MRK HIV ISENTRESS MSD NYSE:MRK Source Type: news
Merck Announces Second-Quarter 2016 Financial Results
Dateline City:
KENILWORTH, N.J. Second-Quarter 2016 Worldwide Sales Were $9.8 Billion, an Increase of 1 Percent, Including a 2 Percent Negative Impact from Foreign Exchange Second-Quarter 2016 GAAP EPS Was $0.43; Second-Quarter Non-GAAP EPS Was $0.93 Company Updates EPS Guidance: Full-Year 2016 GAAP EPS Range to be Between $1.98 and $2.08; Full-Year 2016 Non-GAAP EPS Range of $3.67 to $3.77 Advanced KEYTRUDA Development Program KEYTRUDA Demonstrated Superior Progression-Free Survival and Overall Survival Compared to Chemotherapy in Patients with Previous...
Source: Merck.com - Corporate News - July 29, 2016 Category: Pharmaceuticals Tags: Corporate News Financial News Latest News #Merck #MRK $MRK earnings MSD NYSE:MRK Source Type: news
Good News, Bad News, on Hypoglycemia in Diabetes in UK Good News, Bad News, on Hypoglycemia in Diabetes in UK
Given the aging population and the risk of hypoglycemia with too tight glycemic control in older diabetic patients,"efforts are required to avoid an increase in hospital admissions," say study authors.Medscape Medical News
Source: Medscape Diabetes Headlines - August 1, 2016 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Good News/Bad News
So the good news is that heart disease is becoming less of a problem for many Americans and the death rate is down. But the bad news is thatcancer is beginning to take over as the leading cause of death of Americans. It is already the leading cause of death for Asians and Pacific Islanders.Well whoop de do. Does that make me any less likely to die of heart disease or cancer? Not really.
Source: Caroline's Breast Cancer Blog - August 28, 2016 Category: Cancer & Oncology Tags: ailments bad news good news Source Type: blogs
Previous TOXMAP news archived
TOXMAP news dating back to 2004 is now archived at the TOXMAP classic News page. TOXMAP classic news will continue to appear there. News pertaining to all versions of TOXMAP will appear here.
Source: TOXMAP News - February 27, 2014 Category: Toxicology Authors: TOXMAP Admin Source Type: news
Top 10 Cancer News Stories of 2016
Our team of journalists works hard every day to bring you the latest news and information about cancer topics to keep you informed. We monitor scientific journal articles, government health and cancer reports, and studies from our own American Cancer Society researchers to bring you the news you need about ways to lower your risk from cancer, and ways to cope with the disease.In 2016 we published stories about new findings in cancer risk factors, treatments, and survivorship issues in children and adults. Our writers and editors have chosen the 10 most significant stories of the year.HPV drops since vaccinations began in U...
Source: American Cancer Society :: News and Features - December 29, 2016 Category: Cancer & Oncology Tags: General Information Source Type: news
UK ’ s largest academy trust ’ s caretaker cuts pose serious risk to pupils, say unions
Some schools face losing 50% of caretaking staff under an academy chain’s ‘controversial’ plans released today (Tuesday).
Education unions have issued a warning over plans by London-based Academies Enterprise Trust (AET) to slash £1.4 million from its schools’ estates budgets.
Under the plan AET is proposing to cut the number of buildings and estates staff in schools by over 25%, resulting in at least 34 redundancies across its 66 primary, special and secondary academies.
Schools across the UK are affected – including those in London, Birmingham, Leeds, Bristol, Middlesbrough, Barnsley, Gloucester and M...
Source: UNISON Health care news - May 9, 2017 Category: UK Health Authors: Charlotte Jeffs Tags: News Press release academy schools Caretakers education and training education services Source Type: news
Wolters Kluwer Receives 27 Awards from the American Society of Healthcare Publication Editors (ASHPE) for Editorial and Design Excellence
Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, is pleased to announce that its Lippincott journal portfolio has won 27 awards across 20 categories in the American Society of Healthcare Publication Editors (ASHPE) annual awards competition. ASHPE recognizes member articles and publications for editorial, design, print and online award categories.
“We are very excited for and proud of our editorial and publishing teams for their accomplishments this year,” said Jayne Marks, Vice President, Global Publishing, Wolters Kluwer, Health Learning, Research and...
Source: News from STM - May 16, 2017 Category: Databases & Libraries Authors: STM Publishing News Tags: Featured World Source Type: news
Taylor & Francis partners with The Conversation Africa to boost engagement with African research
Taylor & Francis and The Conversation Africa announce a new partnership to facilitate African researchers increasing public engagement with their work and expertise. By acting as Funding Partner, Taylor & Francis will work with The Conversation Africa to highlight essential African research and offer T&F authors, journal editors, and publishing partners closer links with the African news website.
The Conversation is an international network of news websites, addressing the news agenda from an academic perspective. TC-Africa was established in 2015, joining Conversation websites in Australia, the UK, France and ...
Source: News from STM - June 13, 2017 Category: Databases & Libraries Authors: STM Publishing News Tags: Featured World Source Type: news
Psych News PsychoPharm Reports on Why FDA Took Steps To Encourage Removal of Opana ER From Market
When Endo Pharmaceuticals earlier this monthannounced that the company was pulling its opioid analgesic Opana ER (oxymorphone hydrochloride extended release) from the market, it marked the end of the road for a reformulated medication whose abuse by injection has been associated with multiple disease outbreaks.“We are facing an opioid epidemic—a public health crisis, and we must take all necessary steps to reduce the scope of opioid misuse and abuse,” FDA Commissioner Scott Gottlieb, M.D., said in a press release announcing the agency’s formal request in June that Endo stop selling the medication. The action by the...
Source: Psychiatr News - July 21, 2017 Category: Psychiatry Tags: endo pharmaceuticals FDA hepatitis C HIV opana er Scott Gottlieb substance use disorder thrombotic microangiopathy Source Type: research
EpiPen Alternative Costs $4,500, But Many Get It For Free
NEW YORK (CBS) – After the price of EpiPens rose to more than $600 last year, the ensuing controversy led to the rise of much cheaper generic auto-injectors.
So why is there buzz surrounding a newer alternative that costs $4,500?
The Auvi-Q and the EpiPen (Image credit: CBS This Morning)
CBS News reports that families dealing with life-threatening allergies are looking at the Auvi-Q , which is smaller and comes with a voice instructor. The list price may be expensive, but an affordability program by drugmaker Kaleo means families are paying nothing in out-of-pocket costs.
“It’s an access model built for patients,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 9, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News EpiPen Source Type: news
Despite Setbacks, Search for Alzheimer ’s Therapy Moves Forward
Treatment targeting amyloid beta —a protein that has long been assumed to cause Alzheimer’s disease (AD) through its accumulation in the brain—remains a major focus of research on potential pharmacological treatments, but drug candidates aimed at alternative pathways are catching up in development.Psychiatric News PsychoPharm has compiled alist describing some of the AD drugs in development you may hear more about in the coming year.The most robust group of non-amyloid drugs are agents that targets tau, another protein that can form toxic aggregations in the brain. Two anti-tau monoclonal antibodies —ABBV-8E12 andR...
Source: Psychiatr News - February 5, 2018 Category: Psychiatry Tags: ABBV-8E12 Alzheimer's disease amyloid beta BIIB092 biomarkers drug development lumateperone Psychiatric News PsychoPharm RO7105705 tau Source Type: research
Mass. Researchers May Be On Brink Of Creating Revolutionary, Non-Addictive Painkiller
CAMBRIDGE (CBS NEWS) — Researchers in Massachusetts believe they may be on the brink of creating a revolutionary non-addictive painkiller. Developed by Blue Therapeutics, Blue-181 could be a big step forward in dealing with the growing opioid crisis. The team there said it wanted to make a drug that is a total replacement for the opioids currently on the market – something that people could safely stop using without the possible dangerous side effects.
Mark Loccisano felt a gratification from painkillers with his very first pill. They were prescribed by a doctor for a sports injury. It was the beginning of an opioi...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 8, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Cambridge Local TV opioid crisis Source Type: news
McDonald ’ s, Burger King, Five Guys Among Chains Given ‘ F ’ Over Antibiotics
(CBS News) — Twenty-two of the top 25 U.S. burger chains — including McDonald’s, Burger King, White Castle and Five Guys — received a failing grade in a review assessing their practices and policies on antibiotics use in their beef products. Only two chains were given an “A” rating.
The scores were published Wednesday in a report called “Chain Reaction IV: Burger Edition,” which was produced by the Center for Food Safety, Consumer Reports, Food Animal Concerns Trust, U.S. PIRG Education Fund, Friends of the Earth, and Natural Resources Defense Council.
The report says 22 chai...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 17, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Antibiotics Fast Food Local TV Source Type: news
